219 related articles for article (PubMed ID: 6778328)
21. Incidence of antibiotic-resistant Streptococcus pneumoniae and beta-lactamase-positive Haemophilus influenzae in clinical isolates from patients with otitis media.
McLinn S; Williams D
Pediatr Infect Dis J; 1996 Sep; 15(9 Suppl):S3-9. PubMed ID: 8878239
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of cefaclor in acute otitis media caused by ampicillin-resistant H. influenzae.
Schwartz RH; Rodriguez WJ; Khan WN; Brigham L; Ross S
Clin Pediatr (Phila); 1982 Jul; 21(7):402-4. PubMed ID: 6979453
[TBL] [Abstract][Full Text] [Related]
23. Use of trimethoprim-sulfamethoxazole to prevent bacterial infections in children with acute lymphoblastic leukemia.
Goorin AM; Hershey BJ; Levin MJ; Siber GR; Gelber RD; Flynn K; Lew M; Beckett K; Blanding P; Sallan SE
Pediatr Infect Dis; 1985; 4(3):265-9. PubMed ID: 3889875
[TBL] [Abstract][Full Text] [Related]
24. Treatment of ampicillin-resistant acute otitis media in the chinchilla.
Reilly JS; Doyle WJ; Cantekin EI; Supance JS; Kim HK; Rohn DD; Bluestone CD
Arch Otolaryngol; 1983 Aug; 109(8):533-5. PubMed ID: 6307238
[TBL] [Abstract][Full Text] [Related]
25. The increasing incidence of Ampicillin-resistant Haemophilus influenzae. A cause of otitis media.
Schwartz R; Rodriguez W; Khan W; Ross S
JAMA; 1978 Jan; 239(4):320-3. PubMed ID: 22767
[TBL] [Abstract][Full Text] [Related]
26. Trimethoprim-sulfamethoxazole compared with ampicillin in the treatment of acute otitis media.
Shurin PA; Pelton SI; Donner A; Finkelstein J; Klein JO
J Pediatr; 1980 Jun; 96(6):1081-7. PubMed ID: 6966331
[TBL] [Abstract][Full Text] [Related]
27. Hemophilus influenzae respiratory infection in adults. 2. Treatment guidelines.
Parker RH
Postgrad Med; 1983 Mar; 73(3):187-91. PubMed ID: 6600838
[TBL] [Abstract][Full Text] [Related]
28. Antimicrobial susceptibility of Haemophilus influenzae isolates collected from 4 centers in Brazil (1990-2003).
de Almeida AE; de Filippis I; Ferreira DG; de Abreu AO; Rebelo C; Gemal AL; Marzochi KB
Diagn Microbiol Infect Dis; 2006 Jan; 54(1):57-62. PubMed ID: 16290031
[TBL] [Abstract][Full Text] [Related]
29. Randomized clinical trial of rifampin-trimethoprim and sulfamethoxazole-trimethoprim in the treatment of localized urinary tract infections.
Stein GE; Gurwith D; Gurwith M
Antimicrob Agents Chemother; 1988 Jun; 32(6):802-6. PubMed ID: 3046481
[TBL] [Abstract][Full Text] [Related]
30. Molecular Epidemiology of Ampicillin-resistant Haemophilus influenzae Causing Acute Otitis Media in Japanese Infants and Young Children.
Kakuta R; Yano H; Hidaka H; Kanamori H; Endo S; Ichimura S; Ogawa M; Shimojima M; Ozawa D; Inomata S; Tanouchi A; Kaku M; Katori Y
Pediatr Infect Dis J; 2016 May; 35(5):501-6. PubMed ID: 26808724
[TBL] [Abstract][Full Text] [Related]
31. Susceptibility studies of multiply resistant Haemophilus influenzae isolated from pediatric patients and contacts.
Campos J; Garcia-Tornel S; Sanfeliu I
Antimicrob Agents Chemother; 1984 Jun; 25(6):706-9. PubMed ID: 6611134
[TBL] [Abstract][Full Text] [Related]
32. Acute otitis media secondary to ampicillin-resistant H. influenzae.
Schwartz RH; Rodriguez WJ; Barsanti RG; Khan WN
Ear Nose Throat J; 1984 Mar; 63(3):161-6. PubMed ID: 6609059
[No Abstract] [Full Text] [Related]
33. Trimethoprim-sulfamethoxazole treatment of persistent otitis media with effusion.
Schwartz RH; Rodriguez WJ
Pediatr Infect Dis; 1982; 1(5):333-5. PubMed ID: 7155965
[TBL] [Abstract][Full Text] [Related]
34. Elaboration of type b capsule by Haemophilus influenzae as a determinant of pathogenicity and impaired killing by trimethoprim-sulfamethoxazole.
Yogev R; Moxon ER
J Clin Invest; 1982 Mar; 69(3):658-65. PubMed ID: 6977557
[TBL] [Abstract][Full Text] [Related]
35. Incidence of ampicillin-resistant Hemophilus influenzae in otitis media.
Syriopoulou V; Scheifele D; Howie V; Ploussard J; Sloyer J; Smith AL
J Pediatr; 1976 Nov; 89(5):839-41. PubMed ID: 1086351
[TBL] [Abstract][Full Text] [Related]
36. Interpretive criteria and quality control parameters for testing of susceptibilities of Haemophilus influenzae and Streptococcus pneumoniae to trimethoprim and trimethoprim-sulfamethoxazole. The Antimicrobial Susceptibility Testing OC Group.
Fuchs PC; Barry AL; Brown SD
J Clin Microbiol; 1997 Jan; 35(1):125-31. PubMed ID: 8968893
[TBL] [Abstract][Full Text] [Related]
37. A randomized controlled trial of cefaclor compared with trimethoprim-sulfamethoxazole for treatment of acute otitis media.
Marchant CD; Shurin PA; Turcyzk VA; Feinstein JC; Johnson CE; Wasikowski DE; Knapp LJ; Tutihasi MA
J Pediatr; 1984 Oct; 105(4):633-8. PubMed ID: 6384453
[TBL] [Abstract][Full Text] [Related]
38. Ampicillin-resistant Haemophilus in the oropharynx: prevalence in three groups of young, middle-class children.
Schwartz RH; Rodriguez WJ; Bryan C
Pediatrics; 1983 Oct; 72(4):464-8. PubMed ID: 6604255
[TBL] [Abstract][Full Text] [Related]
39. Bacteriologic and clinical efficacy of trimethoprim-sulfamethoxazole for treatment of acute otitis media.
Leiberman A; Leibovitz E; Piglansky L; Raiz S; Press J; Yagupsky P; Dagan R
Pediatr Infect Dis J; 2001 Mar; 20(3):260-4. PubMed ID: 11303827
[TBL] [Abstract][Full Text] [Related]
40. Quantitative inhibition of Haemophilus influenzae by trimethoprim/sulfamethoxazole.
Pelton SI; Shurin PA; Klein JO; Finland M
Antimicrob Agents Chemother; 1977 Dec; 12(6):649-54. PubMed ID: 303886
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
